Literature DB >> 31728055

Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML.

Zhuo Ren1, Mariusz Shrestha2,3, Takashi Sakamoto4, Tali Melkman1, Li Meng1, Rob A Cairns4, Eldad Zacksenhaus2,3,5, Tak W Mak1,4,5, Vuk Stambolic1,5, Mark D Minden6,7, Jiance Atom Wang1,5.   

Abstract

Entities:  

Keywords:  AKT Signaling; Acute Myeloid Leukemia (AML); NPM1c Mutation; Nucleophosmin (NPM1); Physical Interaction

Mesh：

Substances：

Year:  2019        PMID： 31728055     DOI： 10.1038/s41375-019-0621-7

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  Nucleophosmin and cancer.

Authors:  Silvia Grisendi; Cristina Mecucci; Brunangelo Falini; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  Osmotic stress as a factor in the detrimental effect of glycerol on human platelets.

Authors:  W J Armitage
Journal:  Cryobiology       Date:  1986-04       Impact factor: 2.487

3.  [Protein fractions of the serum in patients with sciatic pain].

Authors:  H Chmielewski
Journal:  Pol Tyg Lek       Date:  1967-12-18

Review 4.  [On the biochemistry of thrombins].

Authors:  P Walsmann; F Markwardt
Journal:  Pharmazie       Date:  1968-11       Impact factor: 1.267

5.  Renin extraction by the human liver.

Authors:  A R Christlieb; N P Couch; E A Amsterdam; S J Dobrzinsky; R B Hickler
Journal:  Proc Soc Exp Biol Med       Date:  1968-07
  5 in total
  3 in total

1.  P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.

Authors:  Kevin H Lin; Justine C Rutter; Abigail Xie; Shane T Killarney; Camille Vaganay; Chaima Benaksas; Frank Ling; Gaetano Sodaro; Paul-Arthur Meslin; Christopher F Bassil; Nina Fenouille; Jacob Hoj; Rachel Washart; Hazel X Ang; Christian Cerda-Smith; Paul Chaintreuil; Arnaud Jacquel; Patrick Auberger; Antoine Forget; Raphael Itzykson; Min Lu; Jiaxing Lin; Mariaelena Pierobon; Zhecheng Sheng; Xinghai Li; Ashutosh Chilkoti; Kouros Owzar; David A Rizzieri; Timothy S Pardee; Lina Benajiba; Emanuel Petricoin; Alexandre Puissant; Kris C Wood
Journal:  Nat Cancer       Date:  2022-06-06

2.  Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis.

Authors:  Qiaoling Xiao; Li Lei; Jun Ren; Meixi Peng; Yipei Jing; Xueke Jiang; Junpeng Huang; Yonghong Tao; Can Lin; Jing Yang; Minghui Sun; Lisha Tang; Xingyu Wei; Zailin Yang; Ling Zhang
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

3.  Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).

Authors:  Mahmoud Hallal; Sophie Braga-Lagache; Jovana Jankovic; Cedric Simillion; Rémy Bruggmann; Anne-Christine Uldry; Ramanjaneyulu Allam; Manfred Heller; Nicolas Bonadies
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.